skyrizi and tirzepatide Pharma 50: Keytruda holds the top brand slot, but semaglutide have already passed it at the molecule level in FY2025 Lilly launches lower-price weight loss

Weekly dosing patients can continue taking these injections once per week but at a lower dose

The middle path is a step-down, not a discontinuation

Hydration and Electrolyte Replacement Dehydration is one of the most common and overlooked causes of fatigue on tirzepatide

Retatrutide (Triple Agonist) Retatrutide is a first-in-class triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, producing the most profound metabolic effects seen in obesity research to date

For people transitioning specifically because of metabolic health concerns beyond weight, this distinction matters enormously